1982
DOI: 10.1016/s0046-8177(82)80221-9
|View full text |Cite
|
Sign up to set email alerts
|

IgA nephropathy: Morphologic predictors of progressive renal disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

7
169
2
2

Year Published

1984
1984
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 287 publications
(180 citation statements)
references
References 11 publications
7
169
2
2
Order By: Relevance
“…The amount of proleinuria and the severity of mesangial sclerotic changes are reported to be the most important faetors in assessing the prognosis of human giomerulonephritis. especially IgA nephropathy [21][22][23][24][25][26][27][28][29]; however, the relationship belween these changes is not completely understood. The mechanisms of proiciiuiria and sclerotic change as a result of mesangial cell injury induced by immune reactions on mesangial eell surfaces are unknown, though both changes were confirmed to be complement-dependent lesions (Table I).…”
Section: Discussionmentioning
confidence: 99%
“…The amount of proleinuria and the severity of mesangial sclerotic changes are reported to be the most important faetors in assessing the prognosis of human giomerulonephritis. especially IgA nephropathy [21][22][23][24][25][26][27][28][29]; however, the relationship belween these changes is not completely understood. The mechanisms of proiciiuiria and sclerotic change as a result of mesangial cell injury induced by immune reactions on mesangial eell surfaces are unknown, though both changes were confirmed to be complement-dependent lesions (Table I).…”
Section: Discussionmentioning
confidence: 99%
“…IgA nephropathy (IgAN), which is characterized by IgA deposition in the glomerular mesangium and is associated with a wide variability of clinical and pathologic presentations, is the most common glomerular disease worldwide (1)(2)(3). Histopathologic lesions have been reported as risk factors for the progression of IgAN (4).…”
Section: Introductionmentioning
confidence: 99%
“…It is noteworthy that few randomized therapeutic trials included pathologic factors as inclusion criteria (2). Many classifications had been proposed over the years, on the basis of either classes or semiquantitative scores (3)(4)(5)(6)(7)(8)(9)(10). These in-house classifications were mostly in use in single centers, making comparisons, at best, difficult.…”
Section: Introductionmentioning
confidence: 99%